VR Expands Bonita Property and Plans for 2019 Exploration on the Porphyry Copper-Gold System in Nevada
VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) — VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCBB: VRRCF), the “Company”, […]
Interpublic Increases Common Stock Dividend by 12%
New York, Feb. 13, 2019 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) today announced that the company’s Board of Directors […]
TSX News -
Restructured Barrick Picks Up Speed as New Executive Teams Get Down to Business
All amounts expressed in U.S. dollars unless otherwise indicated TORONTO, Feb. 13, 2019 (GLOBE NEWSWIRE) — Barely six weeks after […]
Interpublic Announces Full Year and Fourth Quarter 2018 Results
New York, Feb. 13, 2019 (GLOBE NEWSWIRE) — Q4 2018 net revenue grew 13.3% to $2.41 billion, with strong organic […]
Nash Pharmaceuticals to Present Data on Its Inflammatory Bowel Disease Research Program at The Digestive Disease Week Annual Conference
VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) — Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) […]
Summit Doses First Patient in Phase 3 Clinical Trials of Precision Antibiotic Ridinilazole for C. Difficile Infection
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Doses First Patient in Phase 3 Clinical Trials of Precision Antibiotic Ridinilazole […]
Gaming and Leisure Properties, Inc. Announces Fourth Quarter and Full Year 2018 Results
– Record Revenues for the Fourth Quarter and Full Year –– Establishes 2019 First Quarter and Full Year Guidance – […]
Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations
Issuance of new patents strengthens the intellectual property around Melt Pharmaceuticals’ flagship drug candidate and potential label extensions SAN DIEGO […]
ContraFect Announces Oral Presentation at the 2019 Gordon Research Conference on Mechanisms and Application: Realizing the Potential of Antimicrobial Host Defense Peptides for Human and Veterinary Medicine
YONKERS, N.Y., Feb. 13, 2019 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]
Natus Medical Announces Fourth Quarter and Full Year 2018 Financial Results
Reports record fourth quarter revenue of $141.0 million Reports fourth quarter GAAP loss per share of $0.35 and non-GAAP earnings […]
